Nucleolin overexpression in breast cancer cell sub-populations with different stem-like phenotype enables targeted intracellular delivery of synergistic drug combination.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Biomaterials

• Publication date

  2015-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.biomaterials.2015.08.007PMID 26283155
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bridging cancer biology and the patients' needs with nanotechnology-based approaches.

  2014cited by this paper
• Simultaneous active intracellular delivery of doxorubicin and C6-ceramide shifts the additive/antagonistic drug interaction of non-encapsulated combination.

  2014cited by this paper
• Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity.

  2013cited by this paper
• CD44 regulates vascular endothelial barrier integrity via a PECAM-1 dependent mechanism

  2013cited by this paper
• CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer.

  2013cited by this paper
• Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors.

  2013cited by this paper
• Efficient intracellular delivery of siRNA with a safe multitargeted lipid-based nanoplatform.

  2013cited by this paper
• Tumorsphere assay provides more accurate prediction of in vivo responses to chemotherapeutics

  2013cited by this paper
• A possible usage of a CDK4 inhibitor for breast cancer stem cell-targeted therapy.

  2013cited by this paper
• Impact of anti-PLK1 siRNA-containing F3-targeted liposomes on the viability of both cancer and endothelial cells.

  2013cited by this paper
• Nanoparticle delivery of cancer drugs.

  2012cited by this paper
• Cancer stem cell markers in breast neoplasias: their relevance and distribution in distinct molecular subtypes

  2012cited by this paper
• VS-5584, a Novel and Highly Selective PI3K/mTOR Kinase Inhibitor for the Treatment of Cancer

  2012cited by this paper
• Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells

  2012cited by this paper
• Cancer stem cells: current status and evolving complexities.

  2012cited by this paper
• Doxil®--the first FDA-approved nano-drug: lessons learned.

  2012cited by this paper
• Breast-cancer stem cells-beyond semantics.

  2012cited by this paper
• Expression of the pluripotency markers Oct3/4, Nanog and Sox2 in human breast cancer cell lines.

  2012cited by this paper
• Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links.

  2012cited by this paper
• Targeted and intracellular triggered delivery of therapeutics to cancer cells and the tumor microenvironment: impact on the treatment of breast cancer

  2012cited by this paper
• Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia

  2012cited by this paper
• HER2-targeted liposomal doxorubicin displays enhanced anti-tumorigenic effects without associated cardiotoxicity.

  2012cited by this paper
• Nucleolin Maintains Embryonic Stem Cell Self-renewal by Suppression of p53 Protein-dependent Pathway*

  2011cited by this paper
• Energy Metabolism in Human Pluripotent Stem Cells and Their Differentiated Counterparts

  2011cited by this paper
• Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype

  2011cited by this paper
• Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells Is Primarily Due To Isoform ALDH1A3 and Its Expression Is Predictive of Metastasis

  2011cited by this paper
• Pluripotency factor-mediated expression of the leptin receptor (OB-R) links obesity to oncogenesis through tumor-initiating stem cells

  2011cited by this paper
• Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer

  2011cited by this paper
• Cancer stem cell niche: the place to be.

  2011cited by this paper
• A new paradigm for aptamer therapeutic AS1411 action: uptake by macropinocytosis and its stimulation by a nucleolin-dependent mechanism.

  2010cited by this paper
• Use of nanoscale delivery systems to maintain synergistic drug ratios in vivo

  2010cited by this paper
• Tumor-initiating cells are rare in many human tumors.

  2010cited by this paper
• Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature.

  2009cited by this paper
• The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations

  2009cited by this paper
• ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays.

  2009cited by this paper
• Physicochemical and biological characterization of ceramide-containing liposomes: paving the way to ceramide therapeutic application.

  2008cited by this paper
• Simultaneous evaluation of viability and Bcl‐2 in small‐cell lung cancer

  2008cited by this paper
• Efficient tumor formation by single human melanoma cells

  2008cited by this paper
• Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin.

  2007cited by this paper
• Functions of the histone chaperone nucleolin in diseases.

  2007cited by this paper
• Optimizing combination chemotherapy by controlling drug ratios.

  2007cited by this paper
• ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

  2007cited by this paper
• Rational design of cancer-drug combinations.

  2007cited by this paper
• Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient.

  2006cited by this paper
• Electrostatics of PEGylated micelles and liposomes containing charged and neutral lipopolymers.

  2005cited by this paper
• Application of NMR spectroscopy to the characterization of PEG-stabilized lipid nanoparticles.

  2004cited by this paper
• Prospective identification of tumorigenic breast cancer cells

  2003cited by this paper
• Intracellular delivery of ceramide lipids via liposomes enhances apoptosis in vitro.

  2003cited by this paper
• Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels

  2003cited by this paper
• A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo

  2002cited by this paper
• Use of the Post-Insertion Technique to Insert Peptide Ligands into Pre-Formed Stealth Liposomes with Retention of Binding Activity and Cytotoxicity

  2002cited by this paper
• Trypan blue exclusion test of cell viability.

  2001cited by this paper
• Trypan Blue Exclusion Test of Cell Viability

  2001cited by this paper
• Structure and functions of nucleolin.

  1999cited by this paper
• Mice cloned from embryonic stem cells.

  1999cited by this paper

• Tailored Liposomal Nanocarriers for Precision Breast Cancer Therapy

  2026cites this paper
• Dual Aptamers-Based SETDB1 PROTACs as Effective Anti-Tumor Strategies for Breast Cancer.

  2026cites this paper
• Aptamer–liposome targeted nanotherapeutics for cancer therapy: Bibliometric analysis, recent developments and future perspectives

  2026cites this paper
• CRYβB2 is a biomarker for poor prognosis and response to CDK4/6 inhibitors in breast cancer

  2026cites this paper
• A Variation in Thiophene-Extended Nucleosides as Microenvironment-Sensitive Fluorescent Probes

  2026cites this paper
• Acute degradation of nucleolin reveals its novel functions in cell cycle progression and cell division in triple negative breast cancer

  2025cites this paper
• Peptide-targeted nanoparticles for tumor therapy.

  2025cites this paper
• Patient-derived neuroblastoma models are sensitive to nucleolin-recognizing liposomal drugs.

  2025cites this paper
• (Non)canonical Wnt signaling, cytoarchitecture and stemness: new insights from primary nonmetastatic, primary metastatic, regional and distant metastatic models of adrenocortical carcinoma

  2025cites this paper
• Synthesis and Evaluation of AS1411-Lenalidomide-Targeted Degradation Chimera in Antitumor Therapy

  2025cites this paper
• Benchmarking Protein Nanoparticles for Drug Delivery and Clinical Translation

  2025cites this paper
• Nucleolin-targeted carbon/manganese nanoparticles for synergistic anti-tumor therapy.

  2025cites this paper
• Novel Strategy of Antibody Affinity Maturation and Enhancement of Nucleolin‐Mediated Antibody‐Dependent Cellular Cytotoxicity Against Triple‐Negative Breast Cancer

  2025cites this paper
• "Actual" peptide properties required for nanoparticle development in precision cancer therapeutic delivery.

  2025cites this paper
• Multi-scale delivery dynamics of tetrahedral framework nucleic acids: From organ accumulation to subcellular targeting and precision engineering strategies

  2025cites this paper
• Navigating the therapeutic landscape for breast cancer: targeting breast cancer stem cells

  2024cites this paper
• Dual-phase nanoscissors disrupt vasculature-breast cancer stem cell crosstalk for breast cancer treatment.

  2024cites this paper
• Mesothelin- and nucleolin-specific T cells from combined short peptides effectively kill triple-negative breast cancer cells

  2024cites this paper
• Advancing targeted combination chemotherapy in triple negative breast cancer: nucleolin aptamer-mediated controlled drug release

  2024cites this paper
• Nucleolin acute degradation reveals novel functions in cell cycle progression and division in TNBC

  2024cites this paper
• Dual ligand-targeted Pluronic P123 polymeric micelles enhance the therapeutic effect of breast cancer with bone metastases

  2024cites this paper
• Micelle-based nanoparticles with stimuli-responsive properties for drug delivery

  2024cites this paper
• tRNA-derived fragments: Key determinants of cancer metastasis with emerging therapeutic and diagnostic potentials.

  2024cites this paper
• New Types of Magnetic Nanoparticles for Stimuli‐Responsive Theranostic Nanoplatforms

  2023cites this paper
• Albumin Nanoparticles Surface Decorated with a Tumor-Homing Peptide Help in Selective Killing of Triple-Negative Breast Cancer Cells.

  2023cites this paper
• Nucleolin-based targeting strategies in cancer treatment: Focus on cancer immunotherapy (Review)

  2023cites this paper
• F3 Peptide Functionalized Liquid Crystalline Nanoparticles For Delivering Salinomycin Against Breast Cancer.

  2023cites this paper
• A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer

  2023cites this paper
• Dual-targeted delivery of paclitaxel and indocyanine green with aptamer-modified ferritin for synergetic chemo-phototherapy.

  2023cites this paper
• Emerging role of interactions between tumor angiogenesis and cancer stem cells.

  2023cites this paper
• NIR/pH-triggered aptamer-functionalized DNA origami nanovehicle for imaging-guided chemo-phototherapy

  2023cites this paper
• Anti-nucleolin aptamer mediated specific detection of cancer cells by localized surface plasmon resonance-based U-bent optical fiber

  2023cites this paper
• Functionalized liposomes for targeted breast cancer drug delivery

  2023influential citation
• The Potential of Stem Cells in Treating Breast Cancer.

  2023cites this paper
• Targeted liposomal doxorubicin/ceramides combinations: the importance to assess the nature of drug interaction beyond bulk tumor cells.

  2022cites this paper
• The RGG motif proteins: Interactions, functions, and regulations

  2022cites this paper
• Amelioration of systemic antitumor immune responses in cocktail therapy by immunomodulatory nanozymes

  2022cites this paper
• Nucleolin Overexpression Predicts Patient Prognosis While Providing a Framework for Targeted Therapeutic Intervention in Lung Cancer

  2022cites this paper
• Recent development of aptamer conjugated chitosan nanoparticles as cancer therapeutics.

  2022cites this paper
• Adoptive Transfer of Anti-Nucleolin T Cells Combined with PD-L1 Inhibition against Triple-Negative Breast Cancer

  2022cites this paper
• Detoxification strategies of triptolide based on drug combinations and targeted delivery methods.

  2022cites this paper
• Development of a novel PROTAC using the nucleic acid aptamer as a 1 targeting ligand for tumor selective degradation of nucleolin A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-

  2022cites this paper
• Integration of Palladium Nanoparticles with Surface Engineered Metal-Organic Frameworks for Cell-Selective Bioorthogonal Catalysis and Protein Activity Regulation.

  2022cites this paper
• Progress in cancer drug delivery based on AS1411 oriented nanomaterials

  2022cites this paper
• Development of a novel PROTAC using the nucleic acid aptamer as a targeting ligand for tumor selective degradation of nucleolin

  2021cites this paper
• Trailblazing perspectives on targeting breast cancer stem cells.

  2021cites this paper
• Cancer Stem Cells and Nucleolin as Drivers of Carcinogenesis

  2021cites this paper
• Nanosized Drug Delivery Systems for Breast Cancer Stem Cell Targeting

  2021cites this paper
• Modelling the impact of nucleolin expression level on the activity of F3 peptide-targeted pH-sensitive pegylated liposomes containing doxorubicin

  2021cites this paper
• GMP-grade nanoparticle targeted to nucleolin downregulates tumor molecular signature, blocking growth and invasion, at low systemic exposure

  2021cites this paper
• Chemotherapeutic, Toxin, and Therapeutic Protein Delivery via Nucleolin Aptamer-functionalized Nanoplatforms for Targeted Cancer Therapy

  2021cites this paper
• The Enhanced Efficacy of Intracellular Delivery of Doxorubicin/C6-Ceramide Combination Mediated by the F3 Peptide/Nucleolin System Is Supported by the Downregulation of the PI3K/Akt Pathway

  2021influential citation
• Emerging self-assembling peptide nanomaterial for anti-cancer therapy

  2021cites this paper
• CRYβB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancer

  2021cites this paper
• Stem cell therapy: A paradigm shift in breast cancer treatment

  2021cites this paper
• Peptide-conjugated nanoparticles for targeted photodynamic therapy

  2021cites this paper
• Fabrication of aptamer-guided siRNA loaded lipopolyplexes for gene silencing of notch 1 in MDA-mb-231 triple negative breast cancer cell line

  2021cites this paper
• Chemical Genetic Screen in Drosophila Germline Uncovers Small Molecule Drugs That Sensitize Stem Cells to Insult-Induced Apoptosis

  2021cites this paper
• An insight into aptamer engineered dendrimer for cancer therapy

  2021cites this paper
• Induction of tumor cell apoptosis in human glioblastoma cell lines by cationic peptides

  2021cites this paper
• AS1411 and EpDT3-conjugated silver nanotriangle-mediated photothermal therapy for breast cancer and cancer stem cells.

  2021cites this paper
• Molecularly Engineer Triptolide with Aptamers for High Specifici-ty and Cytotoxicity for Triple-Negative Breast Cancer.

  2020cites this paper
• Ligand-Targeted Delivery of Photosensitizers for Cancer Treatment

  2020influential citation
• Recent advances in drug delivery systems for targeting cancer stem cells

  2020cites this paper
• Aptamer-functionalized Fe3O4@MOF nanocarrier for targeted drug delivery and fluorescence imaging of the triple-negative MDA-MB-231 breast cancer cells

  2020cites this paper
• Matrix Metalloprotease-7 Mediates Nucleolar Assembly and Intra-nucleolar Cleaving p53 in Gefitinib-Resistant Cancer Stem Cells

  2020cites this paper
• Whole Genome and Embryo Transcriptome Analysis of Vertebrate Identifies nxhl Controlling Angiogenesis by Targeting VE-PTP

  2020cites this paper
• Lysosomal Storage Disease-Associated Neuropathy: Targeting Stable Nucleic Acid Lipid Particle (SNALP)-Formulated siRNAs to the Brain as a Therapeutic Approach

  2020cites this paper
• Construction of Nucleolin-Targeted Lipid Nanobubbles and Contrast-Enhanced Ultrasound Molecular Imaging in Triple-Negative Breast Cancer

  2020cites this paper
• Aptamer AS1411 utilized for super-resolution imaging of nucleolin.

  2020cites this paper
• Peptide Targeting Methods

  2020cites this paper
• Cell penetrating peptide-modified nanoparticles for tumor targeted imaging and synergistic effect of sonodynamic/HIFU therapy

  2019cites this paper
• Different localization of fluorescently labeled N- and C-termini of nucleolin variants in human glioblastoma cell culture

  2019cites this paper
• Engineering a Nanostructured Nucleolin-Binding Peptide for Intracellular Drug Delivery in Triple-Negative Breast Cancer Stem Cells.

  2019cites this paper
• Nucleolin Is a Functional Binding Protein for Salinomycin in Neuroblastoma Stem Cells.

  2019cites this paper
• Aptamer-guided upconversion nanoplatform for targeted drug delivery and near-infrared light-triggered photodynamic therapy

  2019cites this paper
• Combination of Doxorubicin with Gemcitabine-Incorporated G-Quadruplex Aptamer Showed Synergistic and Selective Anticancer Effect in Breast Cancer Cells.

  2019cites this paper
• The first integrins β3-mediated cellular and nuclear targeting therapeutics for prostate cancer.

  2019cites this paper
• Nucleolin-based targeting strategies for cancer therapy: from targeted drug delivery to cytotoxic ligands.

  2019cites this paper
• Multifaceted Nucleolin Protein and Its Molecular Partners in Oncogenesis.

  2018cites this paper
• Particles and Nanoparticles in Pharmaceutical Products

  2018influential citation
• Moving Liposome Technology from the Bench to the Oncological Patient: Towards Performance-by-Design

  2018cites this paper
• AML-associated mutation of nucleophosmin compromises its interaction with nucleolin.

  2018cites this paper
• Nucleolin is expressed in patient‐derived samples and glioblastoma cells, enabling improved intracellular drug delivery and cytotoxicity

  2018cites this paper
• Meeting the needs of breast cancer: A nucleolin's perspective.

  2018cites this paper
• Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery

  2017cites this paper
• The cancer stem cell phenotype as a determinant factor of the heterotypic nature of breast tumors.

  2017cites this paper
• New perspectives of physiological and pathological functions of nucleolin (NCL)

  2017cites this paper
• Pathology-Driven Comprehensive Proteomic Profiling of the Prostate Cancer Tumor Microenvironment

  2017cites this paper
• Evaluation of somatostatin and nucleolin receptors for therapeutic delivery in non-small cell lung cancer stem cells applying the somatostatin-analog DOTATATE and the nucleolin-targeting aptamer AS1411

  2017cites this paper
• Defining the Na+/H+ exchanger NHE1 interactome in triple-negative breast cancer cells.

  2017cites this paper
• MDM2 Degrades Deacetylated Nucleolin Through Ubiquitination to Promote Glioma Stem-Like Cell Enrichment for Chemotherapeutic Resistance

  2017cites this paper
• Effects of Cell Adhesion Peptides, pH, and Matrix Shape on Maintenance of Breast Cancer Stem Cells in an Engineered Hydrogel Matrix

  2015cites this paper